Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Talha Badar

Showing results (31-40 of 113) with videos related to

Pageof 12
Sort By:
Journal of Clinical Apheresis|October 1, 2019
An updated single center experience with plerixafor and granulocyte colony-stimulating factor for stem cell mobilization in light chain amyloidosisTalha Badar, Binod Dhakal, Aniko Szabo, et al.
European Journal of Haematology|November 19, 2016
Predictors of inferior clinical outcome in patients with standard-risk multiple myelomaTalha Badar, Samer Srour, Qaiser Bashir, et al.
Transplantation and Cellular Therapy|March 30, 2024
Efficacy of Autologous and Allogeneic Hematopoietic Cell Transplantation in Adults with Acute Promyelocytic Leukemia: Results of a Systematic Review and Meta-AnalysisRazan Mohty, Tea Reljic, Farah Yassine, et al.
Leukemia Research|July 18, 2015
Therapeutic benefit of decitabine, a hypomethylating agent, in patients with high-risk primary myelofibrosis and myeloproliferative neoplasm in accelerated or blastic/acute myeloid leukemia phaseTalha Badar, Hagop M Kantarjian, Farhad Ravandi, et al.
British Journal of Haematology|September 15, 2023
Venetoclax plus hypomethylating agents in DDX41-mutated acute myeloid leukaemia and myelodysplastic syndrome: Mayo Clinic series on 12 patientsAhmad Nanaa, Rong He, James M Foran, et al.
Hematology/Oncology and Stem Cell Therapy|March 18, 2026
Effect of Somatic Variants Post Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic SyndromeMadiha Iqbal, Himil Mahadevia, Zhuo Li, et al.
Blood Advances|June 7, 2019
Postrelapse survival in diffuse large B-cell lymphoma after therapy failure following autologous transplantationNarendranath Epperla, Talha Badar, Aniko Szabo, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 7, 2017
New Tool for Monitoring Molecular Response in Patients With Chronic Myeloid LeukemiaTalha Badar, Rajyalakshmi Luthra, Hagop Kantarjian, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 27, 2019
Incidence and characteristics of engraftment syndrome after autologous hematopoietic cell transplantation in light chain amyloidosisTalha Badar, Muhammad Ali Khan, Aniko Szabo, et al.
American Journal of Hematology|January 8, 2026
Post-FDA Approval Experience With Momelotinib in JAK Inhibitor-Naïve Myelofibrosis: Focus on Anemia Response and Treatment-Emergent Nephropathy and Peripheral NeuropathyAyalew Tefferi, Maymona Abdelmagid, Jeanne M Palmer, et al.
Pageof 12

Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
Journal of Clinical Apheresis|October 1, 2019
An updated single center experience with plerixafor and granulocyte colony-stimulating factor for stem cell mobilization in light chain amyloidosisTalha Badar, Binod Dhakal, Aniko Szabo, et al.
European Journal of Haematology|November 19, 2016
Predictors of inferior clinical outcome in patients with standard-risk multiple myelomaTalha Badar, Samer Srour, Qaiser Bashir, et al.
Transplantation and Cellular Therapy|March 30, 2024
Efficacy of Autologous and Allogeneic Hematopoietic Cell Transplantation in Adults with Acute Promyelocytic Leukemia: Results of a Systematic Review and Meta-AnalysisRazan Mohty, Tea Reljic, Farah Yassine, et al.
Leukemia Research|July 18, 2015
Therapeutic benefit of decitabine, a hypomethylating agent, in patients with high-risk primary myelofibrosis and myeloproliferative neoplasm in accelerated or blastic/acute myeloid leukemia phaseTalha Badar, Hagop M Kantarjian, Farhad Ravandi, et al.
British Journal of Haematology|September 15, 2023
Venetoclax plus hypomethylating agents in DDX41-mutated acute myeloid leukaemia and myelodysplastic syndrome: Mayo Clinic series on 12 patientsAhmad Nanaa, Rong He, James M Foran, et al.
Hematology/Oncology and Stem Cell Therapy|March 18, 2026
Effect of Somatic Variants Post Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic SyndromeMadiha Iqbal, Himil Mahadevia, Zhuo Li, et al.
Blood Advances|June 7, 2019
Postrelapse survival in diffuse large B-cell lymphoma after therapy failure following autologous transplantationNarendranath Epperla, Talha Badar, Aniko Szabo, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 7, 2017
New Tool for Monitoring Molecular Response in Patients With Chronic Myeloid LeukemiaTalha Badar, Rajyalakshmi Luthra, Hagop Kantarjian, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 27, 2019
Incidence and characteristics of engraftment syndrome after autologous hematopoietic cell transplantation in light chain amyloidosisTalha Badar, Muhammad Ali Khan, Aniko Szabo, et al.
American Journal of Hematology|January 8, 2026
Post-FDA Approval Experience With Momelotinib in JAK Inhibitor-Naïve Myelofibrosis: Focus on Anemia Response and Treatment-Emergent Nephropathy and Peripheral NeuropathyAyalew Tefferi, Maymona Abdelmagid, Jeanne M Palmer, et al.
Pageof 12